BVALX
Price
$14.64
Change
-$0.02 (-0.14%)
Updated
Jul 17 closing price
Net Assets
1.65B
VMVIX
Price
$65.16
Change
+$0.31 (+0.48%)
Updated
Jul 16 closing price
Net Assets
30.57B
Interact to see
Advertisement

BVALX vs VMVIX

Header iconBVALX vs VMVIX Comparison
Open Charts BVALX vs VMVIXBanner chart's image
Brown Advisory BeutelGoodmanLg-CpValInst
Price$14.64
Change-$0.02 (-0.14%)
VolumeN/A
Net Assets1.65B
Vanguard Mid-Cap Value Index Investor
Price$65.16
Change+$0.31 (+0.48%)
VolumeN/A
Net Assets30.57B
BVALX vs VMVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BVALX vs. VMVIX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVALX is a Buy and VMVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 30.6B vs. BVALX (1.65B). VMVIX pays higher dividends than BVALX: VMVIX (2.14) vs BVALX (1.40). BVALX was incepted earlier than VMVIX: BVALX (7 years) vs VMVIX (19 years). BVALX (0.55) is less costly to investors than VMVIX (0.19). BVALX is a more actively managed with annual turnover of: 24.00 vs. VMVIX (19.00). VMVIX has a lower initial minimum investment than BVALX: VMVIX (3000) vs BVALX (1000000). VMVIX annual gain was more profitable for investors over the last year : 4.51 vs. BVALX (-7.44). VMVIX return over 5 years is better than : 66.84 vs. BVALX (44.05).
BVALXVMVIXBVALX / VMVIX
Total Expense Ratio0.550.19289%
Annual Report Gross Expense Ratio0.550.19289%
Fund Existence7 years19 years-
Gain YTD-0.0681.893-4%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.65B30.6B5%
Annual Yield % from dividends1.402.1466%
Returns for 1 year-7.444.51-165%
Returns for 3 years24.2726.9890%
Returns for 5 years44.0566.8466%
Returns for 10 yearsN/A84.01-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INBX23.650.69
+3.01%
Inhibrx Biosciences Inc.
ALGS8.680.18
+2.12%
Aligos Therapeutics Inc
OCSL14.610.16
+1.11%
Oaktree Specialty Lending Corp
WTFCM25.00N/A
N/A
Wintrust Financial Corp
CMA61.14-0.09
-0.15%
Comerica